Marc A Dall'Era

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Differential expression of CD10 in prostate cancer and its clinical implication
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, WA, USA
    BMC Urol 7:3. 2007
  2. doi Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Nat Clin Pract Urol 5:277-83. 2008
  3. doi Active surveillance for early-stage prostate cancer: review of the current literature
    Marc A Dall'Era
    Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:1650-9. 2008
  4. ncbi HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, Washington, USA
    Prostate 67:714-21. 2007
  5. doi Active surveillance for the management of prostate cancer in a contemporary cohort
    Marc A Dall'Era
    Department of Urology and the Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:2664-70. 2008
  6. pmc Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival
    Jason L Nelles
    University of California San Francisco, San Francisco, California 94143, USA
    J Urol 180:1933-6; discussion 1936-7. 2008
  7. doi Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
    Marc A Dall'Era
    Department of Urology, University of California, Davis, Sacramento, CA 95817, USA
    BJU Int 107:1232-7. 2011
  8. doi Economic analysis of active surveillance for localized prostate cancer
    Sun Kim
    Department of Urology, School of Medicine, University of California, Davis, California, USA
    Curr Opin Urol 22:247-53. 2012
  9. doi Active surveillance for prostate cancer: a systematic review of the literature
    Marc A Dall'Era
    Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Eur Urol 62:976-83. 2012
  10. ncbi Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
    J Urol 174:1785-8; discussion 1788. 2005

Detail Information

Publications81

  1. pmc Differential expression of CD10 in prostate cancer and its clinical implication
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, WA, USA
    BMC Urol 7:3. 2007
    ..We hypothesize that prostate tumors expressing high levels of CD10 have a more aggressive biology with an early propensity towards lymph node metastasis...
  2. doi Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Nat Clin Pract Urol 5:277-83. 2008
    ..The psychosocial impact of active surveillance on patients is discussed as well as contemporary methods for disease monitoring...
  3. doi Active surveillance for early-stage prostate cancer: review of the current literature
    Marc A Dall'Era
    Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:1650-9. 2008
    ..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
  4. ncbi HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, Washington, USA
    Prostate 67:714-21. 2007
    ..In this study, we compared CD10 mRNA and protein expression between benign and malignant prostate cells and employed proteomic analysis to identify proteins that interact with CD10 in C4-2 prostate cancer cells...
  5. doi Active surveillance for the management of prostate cancer in a contemporary cohort
    Marc A Dall'Era
    Department of Urology and the Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:2664-70. 2008
    ..In this article, the authors report their experience in a contemporary cohort of men with prostate cancer who were managed with active surveillance...
  6. pmc Urethrectomy following cystectomy for bladder cancer in men: practice patterns and impact on survival
    Jason L Nelles
    University of California San Francisco, San Francisco, California 94143, USA
    J Urol 180:1933-6; discussion 1936-7. 2008
    ..We describe the frequency of urethrectomy by bladder cancer stage and identify clinical characteristics that predict urethrectomy. We also investigated whether urethrectomy offers any additional independent survival benefit...
  7. doi Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
    Marc A Dall'Era
    Department of Urology, University of California, Davis, Sacramento, CA 95817, USA
    BJU Int 107:1232-7. 2011
    ....
  8. doi Economic analysis of active surveillance for localized prostate cancer
    Sun Kim
    Department of Urology, School of Medicine, University of California, Davis, California, USA
    Curr Opin Urol 22:247-53. 2012
    ..The purpose of this review is to analyze the economics of active surveillance in comparison with other therapies...
  9. doi Active surveillance for prostate cancer: a systematic review of the literature
    Marc A Dall'Era
    Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Eur Urol 62:976-83. 2012
    ..Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions...
  10. ncbi Comparison of the incidence of latent prostate cancer detected at autopsy before and after the prostate specific antigen era
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
    J Urol 174:1785-8; discussion 1788. 2005
    ..To determine if significant differences exist in the prevalence of latent prostate cancer between periods before and after the advent of screening for prostate cancer, we compared 2 groups of men undergoing autopsy during the 2 periods...
  11. ncbi Does the interval between prostate biopsy and radical prostatectomy affect the immediate postoperative outcome?
    Daniel K Lee
    Department of Urology, University of Iowa, Iowa City, IA, USA
    BJU Int 97:48-50. 2006
    ..To determine whether the interval between prostate biopsy and radical prostatectomy (RP) affects the immediate postoperative outcome...
  12. ncbi Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample
    Fadi N Joudi
    Department of Urology, University of Iowa, Iowa City, Iowa, USA
    J Urol 177:1709-14. 2007
    ..We determined the frequency and predictors of complications of partial and total nephrectomy in a population based sample...
  13. ncbi Watchful waiting versus active surveillance: appropriate patient selection
    Marc A Dall'Era
    Division of Urology, University of California, San Diego, UCSD Medical Center, 200 West Arbor Drive 8897, San Diego, CA 92103, USA
    Curr Urol Rep 9:211-6. 2008
    ..Finally, we support well-designed prospective clinical trials that evaluate active surveillance compared with immediate definitive treatment...
  14. doi Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus
    Badrinath R Konety
    University of Iowa Department of Urology, Iowa City, Iowa, USA
    Urology 71:511-4. 2008
    ..Because there are no currently established guidelines for screening and management of prostate cancer in elderly men (older than 75 years), a multidisciplinary panel was convened to develop consensus recommendations...
  15. ncbi Factors affecting outcomes after radical cystectomy in African Americans
    Badrinath R Konety
    Department of Urology, University of California San Francisco, San Francisco, California 94143 1695, USA
    Cancer 109:542-8. 2007
    ..The authors hypothesized that differences in hospital volume where patients undergo radical cystectomy may be responsible for race-based differences in outcomes after the procedure...
  16. ncbi Complications rates of non-oncologic urologic procedures in population-based data: a comparison to published series
    David S Aaronson
    Department of Urology, University of California San Francisco, San Francisco, CA 94117, USA
    Int Braz J Urol 36:548-56. 2010
    ..We sought to compare complication and mortality rates following urologic procedures derived from population-based data to those of published single-institutional case series...
  17. ncbi Mortality after major surgery for urologic cancers in specialized urology hospitals: are they any better?
    Badrinath R Konety
    Department of Urology, Carver College of Medicine and College of Public Health, University of Iowa, Iowa City, IA, USA
    J Clin Oncol 24:2006-12. 2006
    ..We sought to determine whether a high volume of unrelated complex procedures or procedures in the same specialty area (urology) could translate into better outcomes after major urologic cancer surgery...
  18. ncbi Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes
    Piyush K Agarwal
    Department of Urology, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, Ohio, USA
    Cancer 112:307-14. 2008
    ..The authors report the likelihood of treatment failure and the outcomes after salvage therapy among men with prostate cancer who initially either received external-beam radiation therapy (EBRT) or underwent radical prostatectomy (RP)...
  19. ncbi Complications after radical cystectomy: analysis of population-based data
    Badrinath R Konety
    Department of Urology, University of California, San Francisco, School of Medicine, UCSF Mt Zion Medical Center, San Francisco, California 94143 1695, USA
    Urology 68:58-64. 2006
    ..Complications after radical cystectomy have been reported from large single-institution series but population-based representative data are lacking...
  20. ncbi Bladder and upper tract urothelial cancer
    Badrinath R Konety
    Department of Urology, University of California San Francisco, San Francisco, CA 94143 1695, USA
    J Urol 177:1636-45. 2007
    ..We quantified the economic impact of caring for patients with bladder and upper tract urothelial cancer, and determined the primary drivers for such costs in the population in the United States...
  21. ncbi Should men over the age of 65 years receive PSA screening? Argument in favor
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, CA 94143, USA
    Nat Clin Pract Urol 5:230-1. 2008
  22. ncbi PSA screening among elderly men with limited life expectancies
    Louise C Walter
    Division of Geriatrics, San Francisco VA Medical Center, California, San Francisco 94121, USA
    JAMA 296:2336-42. 2006
    ..However, there are no large-scale studies of actual PSA screening practices in elderly men, according to life expectancy...
  23. ncbi Practice patterns in screening and management of prostate cancer in elderly men
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, Iowa, USA
    Urology 68:1051-6. 2006
    ..To determine the practice preferences for prostate cancer screening and treatment in men 75 years of age or older among healthcare providers in Iowa...
  24. doi Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE
    Badrinath R Konety
    Department of Urology and Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 179:1797-803; discussion 1803. 2008
    ..We examined patterns of primary treatment for prostate cancer in men 75 years or older...
  25. doi Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief?
    David S Aaronson
    UCSF Medical Center, Department of Urology, Ambulatory Care Center, Suite A633, San Francisco, CA 94117, USA
    BJU Int 104:506-9; discussion 509-10. 2009
    ....
  26. doi Effect of uniform consensus recommendations for PCa screening in older population: differential effects and perceptions of healthcare providers and patients
    Badrinath R Konety
    Department of Urology, University of California, San Francisco, School of Medicine, San Francisco, California 94143, USA
    Urology 73:603-8; discussion 608-9. 2009
    ..We also surveyed healthcare providers and men >75 years old to determine whether provider attitudes toward continued PCa screening in older men had changed...
  27. ncbi Recovery of urinary continence following radical prostatectomy: the impact of prostate volume--analysis of data from the CaPSURE Database
    Badrinath R Konety
    Department of Urology, University of California San Francisco and University of California San Francisco Comprehensive Cancer Center, San Francisco, California 94143, USA
    J Urol 177:1423-5; discussion 1425-6. 2007
    ..We determined if prostate volume determined by preoperative transrectal ultrasound could predict recovery of urinary function and continence following radical prostatectomy...
  28. pmc In vivo tumor grading of prostate cancer using quantitative 111In-capromab pendetide SPECT/CT
    Youngho Seo
    Department of Radiology and Biomedical Imaging, University of California, San Francisco, California 94143 0946, USA
    J Nucl Med 51:31-6. 2010
    ..We have developed an in vivo method to quantify antibody uptake using (111)In-capromab pendetide SPECT combined with CT (SPECT/CT). Our goal was to evaluate this method for potential grading of prostate tumors...
  29. ncbi UroVysion testing can lead to early identification of intravesical therapy failure in patients with high risk non-muscle invasive bladder cancer
    Jared M Whitson
    Department of Urology, University of California San Francisco, San Francisco, California, USA
    Int Braz J Urol 35:664-70; discussion 671-2. 2009
    ..In this study, we investigated the ability of UroVysion to assess response to intravesical therapy in patients with high risk superficial bladder tumors...
  30. doi Active surveillance for localized prostate cancer--current practices and recommendations
    Jennifer N Wu
    Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA
    ScientificWorldJournal 10:2352-61. 2010
    ..Ongoing clinical trials with watchful waiting and active surveillance for prostate cancer will ultimately provide improved evidence for managing early, localized disease...
  31. doi Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease
    Marc A Dall'Era
    Urologic Outcomes Research Group, Department of Urology, University of California San Francisco, San Francisco, California, USA
    J Urol 181:1622-7; discussion 1627. 2009
    ..We determined various sociodemographic predictors of prostate cancer risk category at presentation as assessed by serum prostate specific antigen, cancer grade and tumor stage...
  32. ncbi Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, USA
    J Urol 173:2085-9. 2005
    ..We investigated the effect of caps on the use of and outcomes following aggressive surgical treatment (radical cystectomy) in patients with bladder cancer...
  33. ncbi Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program
    Jonathan M Rippentrop
    Department of Urology, The University of Iowa, Iowa City 52242 1089, USA
    Cancer 101:1357-63. 2004
    ....
  34. ncbi Personality, treatment choice and satisfaction in patients with localized prostate cancer
    Craig A Block
    Department of Urology, University of Iowa, Iowa City, IA, USA
    Int J Urol 14:1013-8. 2007
    ..We studied whether patient personality influences treatment choice and overall treatment satisfaction...
  35. doi 18F-FDG PET/CT of transitional cell carcinoma
    Vivek V Patil
    Department of Radiology, University of California San Francisco, San Francisco, CA 94143 0628, USA
    AJR Am J Roentgenol 193:W497-504. 2009
    ..PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease...
  36. ncbi Bladder cancer incidence and risk factors in men with prostate cancer: results from Cancer of the Prostate Strategic Urologic Research Endeavor
    Stephen Boorjian
    Department of Urology, New York Presbyterian Hospital Weill Cornell Medical Center, New York, New York, USA
    J Urol 177:883-7; discussion 887-8. 2007
    ..We evaluated a large disease registry to determine the incidence of bladder cancer in patients with prostate cancer and investigate whether the type of treatment for prostate cancer increased the risk of bladder cancer...
  37. ncbi Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, USA
    J Urol 169:946-50. 2003
    ..We analyzed the impact of lymphadenectomy on disease specific survival in a population based sample of patients with bladder cancer who underwent radical cystectomy...
  38. pmc Contemporary management of muscle-invasive bladder cancer
    Marc A Dall'Era
    Department of Urology, University of California Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA
    Expert Rev Anticancer Ther 12:941-50. 2012
    ..Personalized chemotherapy is currently being actively pursued to target the underlying molecular changes and tailor to individual needs...
  39. doi The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer
    Necole M Streeper
    Department of Urology, University of Iowa, Iowa City, IA 52242 1089, USA
    BJU Int 103:475-9. 2009
    ....
  40. doi The impact of marriage on bladder cancer mortality
    Jason L Nelles
    Department of Urology, School of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    Urol Oncol 27:263-7. 2009
    ..We examined data from the Surveillance, Epidemiology, and End Results (SEER) cancer survival database to see if married patients with bladder cancer had a survival advantage vs. nonmarried patients...
  41. doi Management of localized prostate cancer in men over 65 years
    Matthew R Cooperberg
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Curr Opin Urol 19:309-14. 2009
    ..However, the majority of tumors are still detected among men over 65-years-old. The appropriate management of localized disease among these older men is controversial...
  42. ncbi Prevalence of prostate specific antigen testing for prostate cancer in elderly men
    Damon J Dyche
    Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
    J Urol 175:2078-82. 2006
    ..We investigated the prevalence and outcome of PSA testing for prostate cancer screening or diagnosis in elderly men 75 years or older at our academic medical center...
  43. ncbi Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs
    Aaron T Ludwig
    Department of Urology, University of Iowa College of Medicine, Iowa City, Iowa 52242 1089, USA
    Urology 65:488-92. 2005
    ..To examine the difference in charges and outcomes between patients who underwent radical cystectomy and urinary diversion by a team of two surgeons versus a single surgeon...
  44. ncbi Prostate-specific antigen testing in the elderly: a hard habit to kick?
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, IA 52246, USA
    BJU Int 97:4-5. 2006
  45. ncbi Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, Iowa, USA
    J Urol 173:1695-700. 2005
    ..We determined the influence of hospital and surgeon volume on various outcome parameters after radical cystectomy for bladder cancer...
  46. ncbi Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study
    Badrinath R Konety
    Department of Urology, Memorial Sloan Kettering Cancer Center and Cornell University, New York, New York 10021, USA
    J Urol 171:709-13. 2004
    ....
  47. ncbi Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis
    Fadi N Joudi
    Department of Urology, University of Iowa, Iowa City 52242 1089, USA
    Urology 62:1083-8. 2003
    ..To assess the practice preferences among urologists treating superficial bladder cancer in the United States...
  48. ncbi Influence of post-cystectomy complications on cost and subsequent outcome
    Badrinath R Konety
    Department of Urology, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 177:280-7; discussion 287. 2007
    ..We quantified the impact of specific post-cystectomy complications and combinations thereof in terms of mortality, charges and length of stay...
  49. ncbi Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program
    Badrinath R Konety
    Department of Urology, University of Iowa, 200 Hawkins Drive, 3267 RCP, Iowa City, IA 52242 1089, USA
    J Urol 170:1765-71. 2003
    ..We also examined the correlation between these factors and disease specific survival such aggressive therapy...
  50. doi Outcomes and follow-up strategies for patients on active surveillance
    Marc A Dall'Era
    Department of Urology, University of California, Davis, CA, USA
    Curr Opin Urol 19:258-62. 2009
    ..This approach allows one to limit prostate cancer treatment and any risk of related morbidity to the men who will benefit the most from active intervention...
  51. doi Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures?
    Vincent Fradet
    Department of Urology and Epidemiology, University of California San Francisco, San Francisco, California, USA
    J Urol 181:1054-9; discussion 1059-60. 2009
    ..We hypothesized that the hospital volume of radical cystectomy is an important predictor of complications of other urological procedures...
  52. doi Effect of postcystectomy infectious complications on cost, length of stay, and mortality
    Benjamin J Davies
    Department of Urology, University of California, San Francisco, USA
    Urology 73:598-602. 2009
    ..The economic and clinical effects of infectious complications after radical cystectomy have not been analyzed...
  53. pmc Phase I clinical trial of an adenovirus/prostate-specific antigen vaccine for prostate cancer: safety and immunologic results
    David M Lubaroff
    Department of Urology, University of Iowa, Iowa City, Iowa 52242, USA
    Clin Cancer Res 15:7375-80. 2009
    ..We performed a phase I clinical trial of adenovirus/prostate-specific antigen (PSA) vaccine in men with measurable metastatic hormone-refractory disease...
  54. ncbi Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, 52242, USA
    BJU Int 94:18-21. 2004
  55. doi Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations
    Marc C Smaldone
    Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15232, USA
    J Urol 182:2619-24. 2009
    ..We tested the validity of POSSUM and Portsmouth POSSUM in patients undergoing radical cystectomy with continent diversion...
  56. ncbi Long-term treatment of metastatic renal-cell carcinoma with fluorouracil
    David A Anderson
    Department of Urology, University of Iowa, Iowa City 52242 1089, USA
    Lancet Oncol 5:690-2. 2004
  57. ncbi Trends in regionalization of inpatient care for urological malignancies, 1988 to 2002
    Matthew R Cooperberg
    Urologic Outcomes Research Group, Program in Urologic Oncology, Department of Urology, University of California San Francisco Comprehensive Cancer Center, California 94115 1711, USA
    J Urol 178:2103-8; discussion 2108. 2007
    ..The net effect of these pressures may be the regionalization of care. We quantified trends in the regionalization of inpatient care for urological oncology in a national administrative database...
  58. ncbi Fluorescence cystoscopy and bladder surveillance
    Fadi N Joudi
    Department of Urology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52241, USA
    Curr Opin Urol 14:265-70. 2004
    ..Update on new developments in the field of fluorescence cystoscopy...
  59. ncbi Evaluation of intraprostatic metabolism of 1,25-dihydroxyvitamin D(3) (calcitriol) using a microdialysis technique
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, USA
    Urology 59:947-52. 2002
    ..We used a prostate microdialysis technique to better understand the intraprostatic pharmacokinetics of calcitriol, which in turn would facilitate planning for systemic calcitriol therapy in patients with prostate cancer...
  60. ncbi Quality of life in long-term survivors of bladder cancer
    Veerasathpurush Allareddy
    Department of Urology, University of Iowa, Iowa City, Iowa 52242 1089, USA
    Cancer 106:2355-62. 2006
    ..The quality of life (QOL) of long-term survivors of bladder cancer in a population-based registry was assessed...
  61. ncbi Functional characterization of the bladder cancer marker, BLCA-4
    Thu Suong Van Le
    Department of Urology, University of Pittsburgh and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15232, USA
    Clin Cancer Res 10:1384-91. 2004
    ..Finally, to determine the timing of expression in relation to the observance of bladder cancer, an animal model of the disease was examined...
  62. ncbi Testicular recurrence from "primary" retroperitoneal germ cell tumor
    Steven R Mindrup
    Department of Urology, University of Iowa School of Medicine, Iowa City, Iowa 52242 1089, USA
    Urology 64:1031. 2004
    ..This presents an interesting dilemma as to whether this was recurrence of the original tumor or a new, primary tumor. The patient's outcome and surveillance protocol for these tumors are presented...
  63. doi Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer
    Andrea C Fang
    Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California, USA
    Cancer 116:1901-8. 2010
    ..Lymph node counts are often a proxy for the extensiveness of a dissection. In the current study, the impact of an institutional policy requiring a minimum number of lymph nodes was assessed...
  64. ncbi The prevalence of renal cell carcinoma diagnosed at autopsy
    Steven R Mindrup
    Department of Urology, University of Iowa, 200 Hawkins Drive, 3 RCP, Iowa City, IA 52242 1089, USA
    BJU Int 95:31-3. 2005
    ....
  65. ncbi Surgical enucleation for the treatment of renal tumors
    Michael E Franks
    Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Urol Int 71:184-9. 2003
    ..We analyzed our institutional experience with surgical enucleation for the primary treatment of small renal tumors...
  66. ncbi Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy
    Fadi N Joudi
    Department of Urology, University of Iowa, Iowa City, IA 52242 1089, USA
    Urol Oncol 24:403-6. 2006
    ..The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases...
  67. ncbi High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey
    Clareann H Bunker
    Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Cancer Epidemiol Biomarkers Prev 11:726-9. 2002
    ..These data support the hypothesis that populations of African descent share genetic and/or lifestyle factors that contribute to their elevated risk for prostate cancer...
  68. ncbi Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer
    Sue A Joslyn
    Division of Health Promotion and Education, University of Northern Iowa, Cedar Falls, Iowa, USA
    Urology 68:121-5. 2006
    ..We sought to determine whether more extended lymphadenectomy, along with radical prostatectomy, resulted in a decreased risk of prostate cancer-specific death at 10 years...
  69. ncbi Prostate cancer screening parameters in a high-risk African-Caribbean population
    Clareann H Bunker
    Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15261, USA
    Urology 63:737-41. 2004
    ..To estimate the prostate cancer screening parameters in a population-based study of African-Caribbean men from the Island of Tobago...
  70. ncbi Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancers
    Veerasathpurush Allareddy
    Department of Health Management and Policy, University of Iowa, Iowa City, Iowa 52242, USA
    Cancer 106:2382-8. 2006
    ..The objectives of this study were to describe the characteristics of patients who were hospitalized for head and neck cancer (HNC) during the years 2000 through 2003 and to identify predictors of in-hospital mortality...
  71. ncbi The impact of provider volume on outcomes from urological cancer therapy
    Fadi N Joudi
    University of Iowa Department of Urology, Iowa City, Iowa 52242, USA
    J Urol 174:432-8. 2005
    ..Growing evidence suggests an association between higher hospital and surgeon volumes, and better outcomes after high risk surgical procedures. We reviewed the literature on volume and outcomes, specifically in urological cancer therapy...
  72. ncbi Sickness and survival in bladder cancer: is comorbidity the crystal ball?
    Badrinath R Konety
    Eur Urol 53:465-7. 2008
  73. ncbi Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database
    Sue A Joslyn
    Division of Health Promotion and Education, University of Northern Iowa, Cedar Falls, Iowa, USA
    Urology 65:675-80. 2005
    ..The benefit of regional lymphadenectomy in patients with primary RCC remains controversial...
  74. ncbi Vitamin D and prostate cancer
    Badrinath R Konety
    Departments of Urology, Pathology, and Pharmacology, University of Pittsburgh, 5200 Centre Avenue, G 40, Pittsburgh, PA 15232, USA
    Urol Clin North Am 29:95-106, ix. 2002
    ..There is now considerable evidence suggesting a role for vitamin D in prostate cancer. In this article, we have reviewed the current evidence supporting the use of vitamin D in the prevention and treatment of prostate cancer...
  75. ncbi Effect of axillary lymphadenectomy on breast carcinoma survival
    Sue A Joslyn
    University of Northern Iowa, 221 WRC, Cedar Falls, IA 50614 0241, USA
    Breast Cancer Res Treat 91:11-8. 2005
    ..To determine the effect of axillary lymphadenectomy on breast carcinoma survival, and to determine racial and age differences in the extent of axillary lymphadenectomy...
  76. ncbi Molecular markers in bladder cancer: a critical appraisal
    Badrinath R Konety
    Department of Urology, University of Iowa, Iowa City, IA 52242, USA
    Urol Oncol 24:326-37. 2006
    ..Further studies involving larger numbers of patients are required to determine their accuracy and widespread applicability in guiding treatment of bladder cancer...
  77. ncbi Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway
    Shinji Urakami
    Department of Urology 112F, Veterans Affairs Medical Center, and University of California at San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
    Clin Cancer Res 12:383-91. 2006
    ..Wnt inhibitory factor-1 (Wif-1) was identified as one of the secreted antagonists that can bind Wnt protein. We hypothesize that Wif-1 plays an important role in bladder cancer pathogenesis...
  78. pmc Specificity of procedure volume and in-hospital mortality association
    Veerajalandhar Allareddy
    Department of Internal Medicine and Pediatrics, MetroHealth Medical Center, Cleveland, OH, USA
    Ann Surg 246:135-9. 2007
    ....
  79. doi A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome
    Vincent Fradet
    BJU Int 101:257-8; author reply 258-9. 2008
  80. ncbi Association between volume and charges for most frequently performed ambulatory and nonambulatory surgery for bladder cancer. Is more cheaper?
    Badrinath R Konety
    Departments of Urology, University of Iowa, 200 Hawkins Drive, 3RCP, Iowa City, Iowa 52242 1089, USA
    J Urol 172:1056-61. 2004
    ..We investigated the relationship between provider volume and charges for transurethral bladder tumor resection (TURBT) and radical cystectomy in patients with bladder cancer...
  81. doi Commentary on the etiologic relationship between prostate radiation and bladder cancer: the scourge for one is poison for the other
    Badrinath R Konety
    J Urol 179:S12-3. 2008